Eliem Therapeutics

-$0.17 (-4.68%) Today
$0.00 (0.00%) As of 8:01 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ELYM and other ETFs, options, and stocks.

About ELYM

Eliem Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy and other disorders of the peripheral and central nervous systems.

CEO
Robert W. Azelby
Employees
19
Headquarters
Redmond, Washington
Founded
2018

ELYM Key Statistics

Market cap
91.92M
Price-Earnings ratio
—
Dividend yield
—
Average volume
445.61K
High today
$3.61
Low today
$3.33
Open price
$3.56
Volume
34.36K
52 Week high
$29.69
52 Week low
$2.61

ELYM Earnings

-$3.11
-$2.07
-$1.04
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.56 per share
Actual
-$0.50 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure